Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial

BACKGROUND: Combining the antibiotic azithromycin and hydroxychloroquine induces airway immunomodulatory effects, with the latter also having in vitro antiviral properties. This may improve outcomes in patients hospitalised for coronavirus disease 2019 (COVID-19). METHODS: Placebo-controlled double-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Respir J
Main Authors: Sivapalan, Pradeesh, Ulrik, Charlotte Suppli, Lapperre, Therese Sophie, Bojesen, Rasmus Dahlin, Eklöf, Josefin, Browatzki, Andrea, Wilcke, Jon Torgny, Gottlieb, Vibeke, Håkansson, Kjell Erik Julius, Tidemandsen, Casper, Tupper, Oliver, Meteran, Howraman, Bergsøe, Christina, Brøndum, Eva, Bødtger, Uffe, Bech Rasmussen, Daniel, Graff Jensen, Sidse, Pedersen, Lars, Jordan, Alexander, Priemé, Helene, Søborg, Christian, Steffensen, Ida E., Høgsberg, Dorthe, Klausen, Tobias Wirenfeldt, Frydland, Martin Steen, Lange, Peter, Sverrild, Asger, Ghanizada, Muhzda, Knop, Filip K., Biering-Sørensen, Tor, Lundgren, Jens D., Jensen, Jens-Ulrik Stæhr
Formato: Artigo
Idioma:Inglês
Publicado em: European Respiratory Society 2022
Assuntos:
Original Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8186006/
https://ncbi.nlm.nih.gov/pubmed/34083403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00752-2021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados